Sera Prognostics, Inc. (SERA)Healthcare | Medical Devices | Salt Lake City, United States | NasdaqGM
2.07 USD
+0.04
(1.970%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 2.00 -0.07 (-0.070%) ⇩ (Aug. 28, 2026, 5:45 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:02 a.m. EDT
This is a distressed biotech play with catastrophic fundamentals that outweigh any speculative catalysts. The company is burning cash aggressively, reporting negative gross margins of -150%, and operating at a massive loss. Despite a 'strong buy' analyst recommendation based on a potential acquisition rumor, the financial reality is dire: the stock has lost nearly 79% of its value over the last four years, and the most recent annual return was a sharp decline. The balance sheet is fragile with negative free cash flow and a debt-to-equity ratio that suggests leverage is becoming a liability as equity shrinks. While the price has recently stabilized near $2, the underlying business model is currently failing to generate revenue or profit. There is no dividend to provide income, and the options market shows no meaningful positioning to suggest a near-term reversal. This is a high-risk speculative vehicle suitable only for investors willing to accept total loss in exchange for a lottery-ticket chance at an acquisition, not a rational investment. |
| Model | MAE |
|---|---|
| MSTL_126 ✓ | 0.099218 |
| MSTL_74_126 | 0.114515 |
| MSTL | 0.150442 |
| AutoETS | 0.160964 |
| AutoARIMA | 0.161667 |
| AutoTheta | 0.164126 |
| MSTL_74 | 0.184228 |
Forecast horizon: 60 days | Selected: MSTL_126
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 0.04 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.019 |
| Excess Kurtosis | -0.45 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 5.054 |
| Revenue per Share | 0.001 |
| Market Cap | 81,660,384 |
| Forward P/E | -3.87 |
| Beta | 0.98 |
| Website | https://www.sera.com |
As of Aug. 22, 2026, 4:02 a.m. EDT: Options activity is extremely sparse with negligible open interest across all strikes. Implied volatility is elevated relative to the low premium prices, suggesting speculative pricing rather than genuine hedging or directional conviction. The lack of significant positioning indicates the market is largely ignoring this instrument for active speculation.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.3903904 |
| Address1 | 2,749 East Parleys Way |
| Address2 | Suite 200 |
| All Time High | 15.5 |
| All Time Low | 1.1 |
| Ask | 2.59 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 21,750 |
| Average Daily Volume3 Month | 37,970 |
| Average Volume | 37,970 |
| Average Volume10Days | 21,750 |
| Beta | 0.984 |
| Bid | 1.4 |
| Bid Size | 2 |
| Book Value | 1.506 |
| City | Salt Lake City |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.07 |
| Current Ratio | 1.976 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 2.09 |
| Day Low | 2.05 |
| Debt To Equity | 5.054 |
| Display Name | Sera Prognostics |
| Earnings Call Timestamp End | 1,786,568,400 |
| Earnings Call Timestamp Start | 1,786,568,400 |
| Earnings Timestamp | 1,786,564,800 |
| Earnings Timestamp End | 1,794,859,200 |
| Earnings Timestamp Start | 1,794,859,200 |
| Ebitda | -36,543,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.046 |
| Enterprise To Revenue | 545.948 |
| Enterprise Value | 38,216,396 |
| Eps Current Year | -0.6575 |
| Eps Forward | -0.535 |
| Eps Trailing Twelve Months | -0.66 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 801 990 6601 |
| Fifty Day Average | 2.01 |
| Fifty Day Average Change | 0.059999943 |
| Fifty Day Average Change Percent | 0.029850718 |
| Fifty Two Week Change Percent | -39.03904 |
| Fifty Two Week High | 3.95 |
| Fifty Two Week High Change | -1.8800001 |
| Fifty Two Week High Change Percent | -0.47594938 |
| Fifty Two Week Low | 1.56 |
| Fifty Two Week Low Change | 0.51 |
| Fifty Two Week Low Change Percent | 0.32692307 |
| Fifty Two Week Range | 1.56 - 3.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,626,355,800,000 |
| Float Shares | 27,758,222 |
| Forward Eps | -0.535 |
| Forward P E | -3.8691585 |
| Free Cashflow | -18,889,624 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 71 |
| Fullday Change | 0.04 |
| Fullday Change Percent | 1.97044 |
| Fullday Price | 2.0 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -1.5 |
| Gross Profits | -105,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11915 |
| Held Percent Institutions | 0.50194 |
| Implied Shares Outstanding | 39,449,466 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-07-15 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. |
| Long Name | Sera Prognostics, Inc. |
| Market | us_market |
| Market Cap | 81,660,384 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_117852744 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -33,233,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 80,082,415 |
| Number Of Analyst Opinions | 2 |
| Open | 2.07 |
| Operating Cashflow | -27,682,000 |
| Operating Margins | -333.46667 |
| Payout Ratio | 0.0 |
| Phone | 801 990 0520 |
| Post Market Change | -0.06999993 |
| Post Market Change Percent | -3.3816395 |
| Post Market Price | 2.0 |
| Post Market Time | 1,787,953,548 |
| Previous Close | 2.03 |
| Price Eps Current Year | -3.1482887 |
| Price Hint | 4 |
| Price To Book | 1.374502 |
| Price To Sales Trailing12 Months | 1,166.5769 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.907 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.04 |
| Regular Market Change Percent | 1.97044 |
| Regular Market Day High | 2.09 |
| Regular Market Day Low | 2.05 |
| Regular Market Day Range | 2.05 - 2.09 |
| Regular Market Open | 2.07 |
| Regular Market Previous Close | 2.03 |
| Regular Market Price | 2.07 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 23,109 |
| Return On Assets | -0.2348 |
| Return On Equity | -0.45029 |
| Revenue Growth | 0.765 |
| Revenue Per Share | 0.001 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 38,481,707 |
| Shares Percent Shares Out | 0.0057 |
| Shares Short | 225,264 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 240,837 |
| Short Name | Sera Prognostics, Inc. |
| Short Percent Of Float | 0.0072000003 |
| Short Ratio | 5.68 |
| Source Interval | 15 |
| State | UT |
| Symbol | SERA |
| Target High Price | 6.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 5.5 |
| Target Median Price | 5.5 |
| Total Cash | 46,445,000 |
| Total Cash Per Share | 1.177 |
| Total Debt | 3,001,000 |
| Total Revenue | 70,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.66 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.402575 |
| Two Hundred Day Average Change | -0.33257508 |
| Two Hundred Day Average Change Percent | -0.13842443 |
| Type Disp | Equity |
| Volume | 23,109 |
| Website | https://www.sera.com |
| Zip | 84,109 |